# Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

> **NCT03888378** · PHASE2 · COMPLETED · sponsor: **Hovione Scientia Limited** · enrollment: 270 (actual)

## Conditions studied

- Meibomian Gland Dysfunction
- MGD-Meibomian Gland Dysfunction

## Interventions

- **DRUG:** 0.3% Topical Minocycline Ointment
- **DRUG:** 1% Topical Minocycline Ointment
- **OTHER:** Topical Vehicle Ointment

## Key facts

- **NCT ID:** NCT03888378
- **Lead sponsor:** Hovione Scientia Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-02
- **Primary completion:** 2020-09-18
- **Final completion:** 2021-02-01
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03888378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03888378, "Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03888378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*